VKH
ATXS

Virtu KCG Holdings’s Astria Therapeutics ATXS Stock Holding History

Virtu KCG Holdings’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$271K Buy
+3,202
New +$267K 0.01% 1792
2016
Q3 		– Sell
-234
Closed -$52K – 3049
2016
Q2 		$52K Buy
+234
New +$70.5K ﹤0.01% 2672

Other funds holding ATXS

SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu KCG Holdings's ATXS Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Astria Therapeutics (ATXS) in Q2 2017: 3,202 shares worth $271K. The stake represents 0.01% of the portfolio and ranks #1792 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in ATXS as recently as Q2 2016.

Virtu KCG Holdings first reported a position in ATXS in Q2 2016 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold ATXS as of Q2 2017.

  • Virtu KCG Holdings held 3,202 shares of Astria Therapeutics worth $271K as of Q2 2017.
  • Astria Therapeutics was a new Virtu KCG Holdings position in Q2 2017.
  • Astria Therapeutics made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1792 holding.
  • Virtu KCG Holdings first reported a position in Astria Therapeutics in Q2 2016 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Astria Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.